P/E Ratio
Price-to-earnings ratio, a valuation metric.
Latest P/E Ratio: 107.1 (2026Q1); +24.2% YoY; +21.3% CAGR since 2013Q3 (12.5y).
Chart and table show the latest 24 of 51 quarters.
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Rule of 40
Quarterly P/E Ratio Data
Chart and table show the latest 24 of 51 quarters.
| Period | Value |
|---|---|
| 2020Q2 | 16.6 |
| 2020Q3 | 14.9 |
| 2020Q4 | 30.6 |
| 2021Q1 | 31.6 |
| 2021Q2 | 25.4 |
| 2021Q3 | 21.7 |
| 2021Q4 | 18.0 |
| 2022Q1 | 20.1 |
| 2022Q2 | 18.9 |
| 2022Q3 | 15.8 |
| 2022Q4 | 21.7 |
| 2023Q1 | 33.8 |
| 2023Q2 | 25.1 |
| 2023Q3 | 37.4 |
| 2023Q4 | 52.5 |
| 2024Q1 | 50.4 |
| 2024Q2 | 53.9 |
| 2024Q3 | 65.2 |
| 2024Q4 | 71.0 |
| 2025Q1 | 86.3 |
| 2025Q2 | 86.3 |
| 2025Q3 | 172.8 |
| 2025Q4 | 96.8 |
| 2026Q1 | 107.1 |
Healthcare Comparison
1 / 3
Other ABBV Charts
More quarter-by-quarter fundamentals for AbbVie Inc.
1 / 8